We are cutting a 2025 superior winner, obtaining profits in the movement of the market towards health actions
We are selling 75 shares of Ge Healthcare at approximately $ 90 each. After Monday's trade, Jim Cramer's charitable trust…
We are selling 75 shares of Ge Healthcare at approximately $ 90 each. After Monday's trade, Jim Cramer's charitable trust…
It's been a topsy-turvy start to 2025 for the stock market. Since the Club's monthly meeting in December, Wall Street…
The healthcare sector is poised to see a rebound and lead the market this year, according to analysts at Strategas,…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Ryanjlane | E+ | fake images The beginning of a new year is the most popular time to make a…
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Life sciences company Danaher certainly hasn't been an easy stock to buy this year. A wave of new companies going…
Eli Lilly has outperformed the S&P 500 for five straight years as Wall Street realized its huge opportunity in obesity…
Rohit Chopra, Director of the CFPB, testifies during the Senate Committee on Banking, Housing and Urban Affairs hearing titled “Semi-Annual…